These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 9480502

  • 1. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M, Fischer A, Turina J, Hess OM.
    Praxis (Bern 1994); 1997 Nov 19; 86(47):1849-53. PubMed ID: 9480502
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P, Vlasínová J, Manousek J, Semrád B, Rysavý F, Lupínek Z, Meluzín J, Vlasicová I, Pirochtová I, Bocek O.
    Vnitr Lek; 1993 Sep 19; 39(9):856-64. PubMed ID: 8212639
    [Abstract] [Full Text] [Related]

  • 3. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M, Szwed H, Kowalik I, Sadowski Z.
    Pol Merkur Lekarski; 2002 Jul 19; 13(73):52-5. PubMed ID: 12362508
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R, Opolski G, Fenyvesi T, Carreer-Bruhwyler F, Dubois C, Famaey JP, Géczy J.
    Int J Cardiol; 2005 Jan 19; 98(1):79-89. PubMed ID: 15676171
    [Abstract] [Full Text] [Related]

  • 5. [Long-term therapy of stress angina pectoris by a single daily administration of 120 mg isosorbide dinitrate in retard form. Comparison of monotherapy and combination therapy with atenolol and nifedipine].
    Blasini R, Brügmann U, Reiniger G, Rudolph W.
    Herz; 1985 Jun 19; 10(3):163-71. PubMed ID: 3926613
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M, de Caprio L, Meccariello P, Cuomo S, Baldini F, D'Ascia C, Steinberg G, Chiariello M.
    Int J Clin Pharmacol Ther Toxicol; 1984 May 19; 22(5):246-9. PubMed ID: 6430811
    [Abstract] [Full Text] [Related]

  • 8. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S, Kolsky H, Moisson P, Valette H.
    Arch Mal Coeur Vaiss; 1981 Apr 19; 74(4):463-71. PubMed ID: 6112971
    [Abstract] [Full Text] [Related]

  • 9. [The effect of molsidomine on bicycle ergometry in patients with stable angina pectoris].
    Rotrekl P, Lupínek Z, Meluzín J, Rysavý F, Lupínková Z.
    Vnitr Lek; 1989 Dec 19; 35(12):1195-202. PubMed ID: 2633458
    [Abstract] [Full Text] [Related]

  • 10. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
    Walker JM, Curry PV, Bailey AE, Steare SE.
    Int J Cardiol; 1996 Feb 19; 53(2):117-26. PubMed ID: 8682597
    [Abstract] [Full Text] [Related]

  • 11. [Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form].
    Vogler AC, Silber S, Spiegelsberger F, Theisen K.
    Z Kardiol; 1989 Jul 19; 78(7):421-6. PubMed ID: 2672652
    [Abstract] [Full Text] [Related]

  • 12. Chronic treatment and tolerance with high doses of isosorbide dinitrate in a slow release form in patients with angina pectoris.
    Becker HJ, Fach WA, Weil J, Hüwer HD.
    Z Kardiol; 1983 Jul 19; 72 Suppl 3():199-202. PubMed ID: 6666222
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M, Sadowski Z.
    Przegl Lek; 2000 Jul 19; 57(9):455-8. PubMed ID: 11199864
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC, Silber S, Vogel M, Theisen K.
    Z Kardiol; 1989 Jul 19; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of antianginal efficacy of long-acting sustained release isosorbide dinitrate in comparison with short-acting isosorbide dinitrate.
    Rao YV, Reddy KS, Wasir HS.
    Indian Heart J; 1991 Jul 19; 43(2):97-100. PubMed ID: 1752623
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation using serial exercise tests of verapamil alone and combined with isosorbide dinitrate in exertional angina].
    Vázquez de Prada JA, Ruano J, Zueco J, Colman T, González-Vílchez F, Pajarón A.
    Rev Esp Cardiol; 1989 Oct 19; 42(8):513-8. PubMed ID: 2602607
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
    Lupanov VP, Alekseeva IA, Vasil'eva NN, Komar OA, Romasiuk SS, Naumov VG.
    Ter Arkh; 2000 Oct 19; 72(9):33-6. PubMed ID: 11076413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.